SCHEMBL19081693

SCHEMBL19081693

c1ccc2c(c1)ccc1oc3cc4c(cc3c12)oc1ccc(-c2c3ccccc3c(-c3ccc5c(c3)oc3ccccc35)c3ccccc23)cc14

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
AHR P35869 4/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 3/20 0.41
NPC1 O15118 3/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ABCG2 Q9UNQ0 4/20 0.40
PAX8 Q06710 2/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
FYN P06241 1/20 0.40
MAPK3 P27361 1/20 0.40
GLA P06280 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23427392 0.97 TDP1 (0.42) TDP1L3MBTL1AHRKDM4EMAPT
SCHEMBL17944240 0.97 TDP1 (0.45) TDP1L3MBTL1AHRKDM4EMAPT
SCHEMBL17945175 0.96 TDP1 (0.48) TDP1L3MBTL1AHRKDM4EMAPT
SCHEMBL22217500 0.94 TDP1 (0.47) TDP1L3MBTL1AHRKDM4EMAPT
SCHEMBL19081706 0.94 TDP1 (0.43) TDP1L3MBTL1AHRKDM4EMAPT
SCHEMBL20127306 0.94 KDM4E (0.45) TDP1L3MBTL1AHRKDM4EMAPT
SCHEMBL23427715 0.93 ABCG2 (0.45) TDP1L3MBTL1AHRKDM4EMAPT
SCHEMBL23426912 0.93 ABCG2 (0.45) TDP1L3MBTL1AHRKDM4EMAPT
SCHEMBL20127580 0.93 TDP1 (0.50) TDP1L3MBTL1AHRKDM4EMAPT
SCHEMBL22218984 0.93 KDM4E (0.44) TDP1L3MBTL1AHRKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885AHR 2453/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885AHR 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.